
Netellis helps biotech and pharma teams find drug candidates faster using AI. It uses a proprietary AI-driven virtual screening platform that analyzes molecular structures and biological data to predict how molecules bind to targets. The system relies on machine learning and deep learning models to evaluate vast chemical libraries across human health, agriculture, and environmental targets. As a B2B SaaS product, it integrates with standard data workflows and supports collaboration across research, discovery, and preclinical teams. The platform aims to reduce time and cost in early drug discovery while enabling scalable screening at large datasets.

Netellis helps biotech and pharma teams find drug candidates faster using AI. It uses a proprietary AI-driven virtual screening platform that analyzes molecular structures and biological data to predict how molecules bind to targets. The system relies on machine learning and deep learning models to evaluate vast chemical libraries across human health, agriculture, and environmental targets. As a B2B SaaS product, it integrates with standard data workflows and supports collaboration across research, discovery, and preclinical teams. The platform aims to reduce time and cost in early drug discovery while enabling scalable screening at large datasets.